If you want to be skeptical of Haidut, fine...... but why don't you have that same skepticism of Glaxo? And the other multi billion dollar pharmaceutical companies?
GlaxoSmithKline Korea said Tuesday it has taken over the largest market share in Japan with its male hair loss treatment Avodart (dutasteride). The news comes on the heels of JW Pharma announcing successful development of a dutasteride tablet generic Monday. According to GSK Korea, Avodart took...
www.koreabiomed.com
So Glaxo is just selling dutasteride out of the goodness of their heart? The almost 1 Billion dollar a year global market isn't a factor at all?
Applying the same logic, why would you buy a hairloss drug from a company whose executives sport these hairlines?
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
www.gsk.com
Anyways, I just threw in one study that Haidut referenced (not conducted, mind you) at the end. That still doesn't take away from everything else I stated.... that baldness is basically a minor problem, all 5AR inhibitors are highly dangerous, that topical contact will lead to systemic absorption (as is even stated in the Avodart commercial), and that Peat does not think endogenous DHT is a problem, and that Peat himself stated it's anti-inflammatory.